Topical Modification of Dental Pain and Movement
Use of Transient Receptor Potential (TRP) modulating topical cream in pain management following wisdom tooth extraction
Professor Peter Smith
60 participants
Oct 1, 2021
Interventional
Conditions
Summary
Wisdom tooth extraction often causes significant local tissue injury in a highly innervated area. This results in significant pain and loss of function. Reduced ability to open the jaw often also accompanies pain and lasts for several days. Dental nerves can express TRPV1, TRPA1 and TRPM3 and are known in allergy work to cause pain when stimulated by inflammatory mediators. Two products, a spray and cream, have been developed that target these receptors via a topical approach. This study will assess pain and mobility after a reproducible "injury" following wisdom teeth surgery, compared to placebo.
Eligibility
Inclusion Criteria1
- Patients undergoing bilateral wisdom tooth extraction, 14 years and over.
Exclusion Criteria1
- Patients with an intolerance to the spray, allergic reaction to spray/placebo ingredients, intellectually disabled participants and persons that speak languages other than English.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Topical application of 2.5g (half a teaspoon) of TRP modulating cream and 1mL of spray following wisdom tooth extraction to the jawline and external cheek at site of wisdom tooth extraction as required for up to five days. Active ingredients are as follows: a. Mentha Arvensis (Peppermint Oil)0.1% b. Chamonilla Recutia (Matricaria) Flower oil 0.05% c. Panax Ginseng Extract 5% d. Aloe Vera powder 0.5% e. Taurine 0.35% f. Glycyrrhiza blabra (Liquorice extract)1% g. Norhydroguiaretic acid 3% h. Epigallocatechin3gallate (EGCG) (Green Tea)0.05% These are compounded with 25% glycerol.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12619001167156